Idera Pharmaceuticals Inc. (NASDAQ: IDRA) Is An Investment You Should Consider If You’re A Risk Taker. – Marketing Sentinel
Home  »  Technologies   »  Idera Pharmaceuticals Inc. (NASDAQ: IDRA) Is An In...

Idera Pharmaceuticals Inc. (NASDAQ: IDRA) Is An Investment You Should Consider If You’re A Risk Taker.

In the latest trading session, 17.88 million Idera Pharmaceuticals Inc. (NASDAQ:IDRA) shares changed hands as the company’s beta touched 1.81. With the company’s most recent per share price at $1.37 changing hands around $0.25 or 22.50% at last look, the market valuation stands at $59.38M. IDRA’s current price is a discount, trading about -348.18% off its 52-week high of $6.14. The share price had its 52-week low at $0.97, which suggests the last value was 29.2% up since then. When we look at Idera Pharmaceuticals Inc.’s average trading volume, we note the 10-day average is 1.17 million shares, with the 3-month average coming to 2.48 million.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Analysts gave the Idera Pharmaceuticals Inc. (IDRA) stock a consensus recommendation rating of a Hold, calculated at a mean rating of 3.00. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 3 recommended IDRA as a Hold, 0 felt it is a Buy and 0 rated the stock as Underweight. Idera Pharmaceuticals Inc.’s EPS for the current quarter is expected to be -$0.18.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Idera Pharmaceuticals Inc. (NASDAQ:IDRA) trade information

Instantly IDRA is in green as seen in intraday trades today. With action -11.81%, the performance over the past five days has been red. The jump to weekly highs of 1.4500 on Monday, 06/21/21 added 22.50% to the stock’s daily price. The company’s shares are showing year-to-date downside of -69.48%, with the 5-day performance at -11.81% in the red. However, in the 30-day time frame, Idera Pharmaceuticals Inc. (NASDAQ:IDRA) is 1.82% up. Looking at the short shares, we see there were 3.7 million shares sold at short interest cover period of 3.51 days.

The consensus price target for the stock as assigned by Wall Street analysts is $1.00, meaning bulls need a downside of -37.0% from its recent market value. According to analyst projections, IDRA’s forecast low is $1.00 with $1.00 as the target high. To hit the forecast high, the stock’s price needs a 27.01% surge from its current level, while the stock would need to tank 27.01% for it to hit the projected low.

Idera Pharmaceuticals Inc. (IDRA) estimates and forecasts

Data shows that the Idera Pharmaceuticals Inc. share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -76.12% over the past 6 months, a 28.70% in annual growth rate that is considerably higher than the industry average of 9.00%. Moreover, analysts have looked to higher expectations by upgrading its fiscal year 2021 revenue estimates. The rating firms predict current quarter revenue for Idera Pharmaceuticals Inc. will rise 75.00%, while the growth in revenue is estimated to hit 69.50% for the next quarter.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 0.30%. The 2021 estimates are for Idera Pharmaceuticals Inc. earnings to decrease by -12.50%.

IDRA Dividends

Idera Pharmaceuticals Inc. is expected to release its next quarterly earnings report in July.

Idera Pharmaceuticals Inc. (NASDAQ:IDRA)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 22.62% of Idera Pharmaceuticals Inc. shares while 19.73% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 25.49%. There are 19.73% institutions holding the Idera Pharmaceuticals Inc. stock share, with Baker Brothers Advisors, LLC the top institutional holder. As of Mar 30, 2021, the company held 4.09% of the shares, roughly 2.05 million IDRA shares worth $2.66 million.

Anson Funds Management LP holds the second largest percentage of outstanding shares, with 3.41% or 1.71 million shares worth $2.22 million as of Mar 30, 2021.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Among Mutual Funds, the top two as of Mar 30, 2021 were Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. With 0.78 million shares estimated at $1.01 million under it, the former controlled 1.55% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.89% of the shares, roughly 0.44 million shares worth around $0.58 million.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

173226

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

173226

100% free. stop anytime no spam